Recent Finacing
Recent Raise
Renovacor is a preclinical biopharmaceutical developing an AAV-based gene replacement therapy for BAG3-mutant dilated cardiomyopathy, advancing toward IND-enabling studies and planned human trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Renovacor.
